Katarzyna Kolasa

Katarzyna Kolasa is a health economist, researcher and independent consultant with over 25 years of international experience across academia, pharmaceutical and medical technology industries, and public healthcare. She develops evidence and value propositions to support investment, commercialisation, pricing and reimbursement of health technologies, with particular expertise in societal and patient preference studies. Her career includes regional and global roles at AstraZeneca, Bristol Myers Squibb, Biogen, Lundbeck, GE Healthcare and Parexel, alongside extensive industry advisory work. As v ice p resident of HEOR at Parexel, she led international teams developing economic models and evidence for healthcare decisions. She has contributed to more than 50 European HTA and pricing and reimbursement processes across oncology, neuroscience, metabolic diseases and other therapeutic areas. Her consulting covers economic evaluation, real-world evidence, market access strategy and managed entr